IndraLab

Statements


Adenosine 5'-monophosphate bound to NLRP3 inhibits NLRP3. 1 / 1
| 1

reach
"Soon afterwards, their data demonstrated that neurotransmitter dopamine (DA) could also inhibit NLRP3 inflammasome activation through dopamine D1 receptor (DRD1), suggesting DRD1 signaling could negatively regulate NLRP3 inflammasome via a second messenger cyclic adenosine monophosphate (cAMP), which binds to NLRP3 and promotes its ubiquitination and degradation."